Related Experiment Video

Updated: Nov 22, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.3K

Doubling Down on Developing Reward System Neurobiology Markers of Antidepressant Treatment Response

Susanna L Fryer1

  • 1Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California San Francisco, and the Mental Health Service, Veterans Affairs San Francisco Healthcare System, San Francisco, California.

Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|January 9, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.8K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.4K

Related Experiment Videos

Last Updated: Nov 22, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.3K
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.8K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.4K

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

608
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
608
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.1K

Articles linked to this work by shared authors, journal, and citation graph.

Metabolic Improvements with a Ketogenic Diet Correlate with Symptom Improvement in Psychosis: A Randomized Controlled Trial.

Schizophrenia bulletin·2026

Parsing Reward Processing Substages With Multimodal EEG-fMRI.

Human brain mapping·2026

Larger Neural Responses to Reward in Gambling Disorder: Relationships With Depression and Gambling Severity.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2025

Adjustment of Regional Cortical Thickness Measures for Global Cortical Thickness Obscures Deficits Across the Schizophrenia Spectrum: A Cautionary Note About Normative Modeling of Brain Imaging Data.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2024

Brain Age Gap in Early Illness Schizophrenia and the Clinical High-Risk Syndrome: Associations With Experiential Negative Symptoms and Conversion to Psychosis.

Schizophrenia bulletin·2024

Cortical and subcortical brain morphometry abnormalities in youth at clinical high-risk for psychosis and individuals with early illness schizophrenia.

Psychiatry research. Neuroimaging·2023

Shared functional abnormalities within somatosensory cortex in obsessive-compulsive disorder and anxiety disorders: A comparative meta-analysis.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026

Distinct Connectivity Signatures of Hallucinatory Experiences and Neuromelanin Signal in Community-Dwelling Adolescents.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026

Effects of polygenic liability for autism on neonatal thalamocortical connectivity and behavioral outcomes across sex.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026

Smoking Cue Reactivity in Relation to Uncertain-Threat and Reward-Anticipation Networks: A Coordinate-Based fMRI Meta-Analysis.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026

Functional brain network correlates of pubertal timing and depressive symptoms in preadolescence.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026

Integrated Investigation of Sex Differences in the Human Nociceptin/Orphanin FQ Receptor System: Postmortem Analyses and In Vivo [11C]NOP-1A Positron Emission Tomography Imaging.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026

Treatment-resistant hypertension in the primary care setting.

Journal of osteopathic medicine·2026

Cognition endpoints for Parkinson's disease: A roadmap for developing patient-focused assessment tools to accelerate drug development.

Journal of Parkinson's disease·2026

Dose-stratified lipid-lowering efficacy and safety of oral PCSK9 inhibitors: a systematic review and meta-analysis.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026

Pharmacological stratification of fall-risk-increasing drugs for prevention of fall-related injuries in older adults: a population-based cohort study.

Age and ageing·2026

Obstetric pharmacoeconomics.

Expert review of pharmacoeconomics & outcomes research·2026

Depot medroxyprogesterone acetate and the risk for developing an intracranial meningioma.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us